IP Verse

Neuefeind competitive analysis

Explore patent oppositions filed by Neuefeind against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Jul 23, 2026

Patent Number	Title	Applicant	Opposition Date
EP4185318	Extended, High Dose Vegf Antagonist Regimens For Treatment Of Angiogenic Eye Disorders	BAYER HEALTHCARE	Jun 2, 2026
EP3487881	Methods Of Treating New-Onset Plaque Type Psoriasis Using Il-17 Antagonists	NOVARTIS	May 20, 2025
EP3330279	Method For Purifying Composition Comprising Antibodies With Anionic Polymer	CHUGAI SEIYAKU KABUSHIKI KAISHA	Jan 5, 2023
EP3393234	Restorer Plants	KWS SAAT	Sep 15, 2022
EP3470432	Methods For Treating Or Preventing Asthma By Administering An Il-4R Antagonist	REGENERON PHARMACEUTICALS	Jul 6, 2022
EP3107575	Methods For Treating Or Preventing Asthma By Administering An Il-4R Antagonist	REGENERON PHARMACEUTICALS	Jun 1, 2022
EP2445924	Capture Purification Processes For Proteins Expressed In A Non-Mammalian System	AMGEN	Dec 3, 2021
EP1915394	High-Level Expression Of Recombinant Antibody In A Mammalian Host Cell	LONZA BIOLOGICS	Oct 26, 2021
EP3234197	Fine Mapping And Validation Of Qtl Underlying Fiber Content And Seed Coat Color Traits And Identification Of Snp Markers For Marker Assisted Selection Of These Traits Derived From Yellow Seed Coat (Ysc) Canola Line Yn01-429 And Its Lineage	DOW AGROSCIENCES	Aug 9, 2021
EP3351620	Metabolically Optimized Cell Culture	REGENERON PHARMACEUTICALS	Jun 2, 2021

Discover the latest PTAB cases involving Neuefeind, highlighting their recent legal challenges and patent disputes.

IP litigation analysis comparing Neuefeind with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Jul 23, 2026

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced
NEUEFEIND	27	-	-	-
CHUGAI SEIYAKU KABUSHIKI KAISHA	3	88	-	1
F HOFFMANN LA ROCHE	16	195	-	-
REGENERON PHARMACEUTICALS	38	120	9	32